Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate vs propofol in elderly patients undergoing ultrasound bronchoscopic mediastinal lymph node biopsy
ChiCTR2400092023Phase 4Not yet recruiting
- Sponsor
- Yan'an Affiliated Hospital of Kunming Medical University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in bronchopulmonary diseases (2 arms), sponsored by Yan'an Affiliated Hospital of Kunming Medical University. Primary endpoint: Quality of awakening. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2400092023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092023.